鳞癌-话题@MedSci

#鳞癌#

133篇内容 | 3397人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1484702, encodeId=70481484e027e, content=<a href='/topic/show?id=3502102944e7' target=_blank style='color:#2F92EE;'>#鳞癌#</a>, objectTitle=Front Oncol：复发或转移性头颈部鳞癌(R/M HNSCC)患者使用免疫检查点抑制剂治疗(ICB)的疗效, objectType=article, longId=295059, objectId=afe5295059f2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=afe5295059f2, replyNumber=0, likeNumber=79, createdTime=2022-02-04, rootId=0, userName=1696533704_45270456, userId=745a7977375, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=afe5295059f2, moduleTitle=Front Oncol：复发或转移性头颈部鳞癌(R/M HNSCC)患者使用免疫检查点抑制剂治疗(ICB)的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=afe5295059f2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1484701, encodeId=32df1484e0162, content=<a href='/topic/show?id=3502102944e7' target=_blank style='color:#2F92EE;'>#鳞癌#</a>, objectTitle=Lancet Gastroenterol Hepatol：郑大一附院王峰教授CAP 02研究显示卡瑞利珠单抗联合阿帕替尼二线治疗晚期食管鳞癌疗效显著, objectType=article, longId=293995, objectId=58f82939954d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=58f82939954d, replyNumber=0, likeNumber=82, createdTime=2022-01-16, rootId=0, userName=1696533704_45270456, userId=745a7977375, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=58f82939954d, moduleTitle=Lancet Gastroenterol Hepatol：郑大一附院王峰教授CAP 02研究显示卡瑞利珠单抗联合阿帕替尼二线治疗晚期食管鳞癌疗效显著, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=58f82939954d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1484699, encodeId=c8af1484699f0, content=<a href='/topic/show?id=3502102944e7' target=_blank style='color:#2F92EE;'>#鳞癌#</a>, objectTitle=Cancer Med：国内多中心随机双盲II期研究表明安罗替尼（Anlotinib）后线治疗较安慰剂改善晚期或转移性食管鳞癌患者的预后, objectType=article, longId=293004, objectId=d88b293004b9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d88b293004b9, replyNumber=0, likeNumber=81, createdTime=2021-12-30, rootId=0, userName=1696533704_45270456, userId=745a7977375, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d88b293004b9, moduleTitle=Cancer Med：国内多中心随机双盲II期研究表明安罗替尼（Anlotinib）后线治疗较安慰剂改善晚期或转移性食管鳞癌患者的预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d88b293004b9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1484700, encodeId=3f721484e00e1, content=<a href='/topic/show?id=3502102944e7' target=_blank style='color:#2F92EE;'>#鳞癌#</a>, objectTitle=J Cancer Res Clin Oncol：广医一院团队真实世界数据发现Sintilimab（信迪利单抗）联合紫杉醇+铂类或可进一步改善晚期肺鳞癌的生存, objectType=article, longId=292997, objectId=720229299ed0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=720229299ed0, replyNumber=0, likeNumber=67, createdTime=2021-12-30, rootId=0, userName=1696533704_45270456, userId=745a7977375, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=720229299ed0, moduleTitle=J Cancer Res Clin Oncol：广医一院团队真实世界数据发现Sintilimab（信迪利单抗）联合紫杉醇+铂类或可进一步改善晚期肺鳞癌的生存, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=720229299ed0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1484698, encodeId=f70614846982b, content=<a href='/topic/show?id=3502102944e7' target=_blank style='color:#2F92EE;'>#鳞癌#</a>, objectTitle=血清HO－1、CA72－4、SCC－Ag联合检测在食管鳞癌诊断中的价值, objectType=article, longId=221122, objectId=e0be2211227f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e0be2211227f, replyNumber=0, likeNumber=62, createdTime=2021-11-28, rootId=0, userName=1696533704_45270456, userId=745a7977375, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e0be2211227f, moduleTitle=血清HO－1、CA72－4、SCC－Ag联合检测在食管鳞癌诊断中的价值, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e0be2211227f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1484697, encodeId=0c68148469e69, content=<a href='/topic/show?id=3502102944e7' target=_blank style='color:#2F92EE;'>#鳞癌#</a>, objectTitle=食管鳞癌放疗患者贫血现状及其对预后的影响研究, objectType=article, longId=221064, objectId=4a41221064d4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4a41221064d4, replyNumber=0, likeNumber=81, createdTime=2021-11-27, rootId=0, userName=1696533704_45270456, userId=745a7977375, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4a41221064d4, moduleTitle=食管鳞癌放疗患者贫血现状及其对预后的影响研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4a41221064d4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1484696, encodeId=b2ee148469659, content=<a href='/topic/show?id=3502102944e7' target=_blank style='color:#2F92EE;'>#鳞癌#</a>, objectTitle=肺癌病例 | 聚焦肺鳞癌，信迪利单抗二线单药治疗经验分享, objectType=article, longId=221017, objectId=e99622101e22, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e99622101e22, replyNumber=0, likeNumber=78, createdTime=2021-11-27, rootId=0, userName=1696533704_45270456, userId=745a7977375, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e99622101e22, moduleTitle=肺癌病例 | 聚焦肺鳞癌，信迪利单抗二线单药治疗经验分享, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e99622101e22)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1484695, encodeId=3c66148469507, content=<a href='/topic/show?id=3502102944e7' target=_blank style='color:#2F92EE;'>#鳞癌#</a>, objectTitle=宫颈腺鳞癌 45 例临床分析, objectType=article, longId=220974, objectId=23792209e4dd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=23792209e4dd, replyNumber=0, likeNumber=74, createdTime=2021-11-26, rootId=0, userName=1696533704_45270456, userId=745a7977375, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=23792209e4dd, moduleTitle=宫颈腺鳞癌 45 例临床分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=23792209e4dd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1484694, encodeId=8f9a1484694a3, content=<a href='/topic/show?id=3502102944e7' target=_blank style='color:#2F92EE;'>#鳞癌#</a>, objectTitle=替吉奥联合同步放疗晚期肺鳞癌及影响因素分析, objectType=article, longId=220707, objectId=25d8220e0776, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=25d8220e0776, replyNumber=0, likeNumber=74, createdTime=2021-11-22, rootId=0, userName=1696533704_45270456, userId=745a7977375, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=25d8220e0776, moduleTitle=替吉奥联合同步放疗晚期肺鳞癌及影响因素分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=25d8220e0776)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1484693, encodeId=d1971484693f3, content=<a href='/topic/show?id=3502102944e7' target=_blank style='color:#2F92EE;'>#鳞癌#</a>, objectTitle=Eur J Cancer：免疫检查点抑制剂在老年头颈部鳞癌患者中的有效性和安全性, objectType=article, longId=217545, objectId=e09321e54552, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e09321e54552, replyNumber=0, likeNumber=85, createdTime=2021-09-25, rootId=0, userName=1696533704_45270456, userId=745a7977375, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e09321e54552, moduleTitle=Eur J Cancer：免疫检查点抑制剂在老年头颈部鳞癌患者中的有效性和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e09321e54552)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1484692, encodeId=5b8214846927a, content=<a href='/topic/show?id=3502102944e7' target=_blank style='color:#2F92EE;'>#鳞癌#</a>, objectTitle=信迪利单抗联合化疗一线治疗食管鳞癌的Ⅲ期临床研究结果公布（ORIENT-15研究）, objectType=article, longId=217411, objectId=2e6921e411bd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2e6921e411bd, replyNumber=0, likeNumber=78, createdTime=2021-09-23, rootId=0, userName=1696533704_45270456, userId=745a7977375, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2e6921e411bd, moduleTitle=信迪利单抗联合化疗一线治疗食管鳞癌的Ⅲ期临床研究结果公布（ORIENT-15研究）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2e6921e411bd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1484691, encodeId=12ce14846919a, content=<a href='/topic/show?id=3502102944e7' target=_blank style='color:#2F92EE;'>#鳞癌#</a>, objectTitle=ESMO Open：Tomuzotuximab vs 西妥昔单抗用作复发/转移性头颈部鳞癌的一线治疗方案的疗效和安全性, objectType=article, longId=217042, objectId=d10c21e042bc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d10c21e042bc, replyNumber=0, likeNumber=70, createdTime=2021-09-15, rootId=0, userName=1696533704_45270456, userId=745a7977375, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d10c21e042bc, moduleTitle=ESMO Open：Tomuzotuximab vs 西妥昔单抗用作复发/转移性头颈部鳞癌的一线治疗方案的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d10c21e042bc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1484690, encodeId=2fc114846909f, content=<a href='/topic/show?id=3502102944e7' target=_blank style='color:#2F92EE;'>#鳞癌#</a>, objectTitle=J Clin Oncol：Veliparib联合卡铂+紫杉醇化疗作为晚期肺鳞癌的一线治疗的效果, objectType=article, longId=216406, objectId=13bc21640686, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=13bc21640686, replyNumber=0, likeNumber=75, createdTime=2021-08-29, rootId=0, userName=1696533704_45270456, userId=745a7977375, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=13bc21640686, moduleTitle=J Clin Oncol：Veliparib联合卡铂+紫杉醇化疗作为晚期肺鳞癌的一线治疗的效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=13bc21640686)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1484689, encodeId=abb51484689eb, content=<a href='/topic/show?id=3502102944e7' target=_blank style='color:#2F92EE;'>#鳞癌#</a>, objectTitle=Eur J Cancer：铂类+5-氟尿嘧啶+西妥昔单抗可作为中国复发/转移性头颈鳞癌患者的新一线治疗方案！, objectType=article, longId=216219, objectId=7cde216219cc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7cde216219cc, replyNumber=0, likeNumber=78, createdTime=2021-08-25, rootId=0, userName=1696533704_45270456, userId=745a7977375, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7cde216219cc, moduleTitle=Eur J Cancer：铂类+5-氟尿嘧啶+西妥昔单抗可作为中国复发/转移性头颈鳞癌患者的新一线治疗方案！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7cde216219cc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1484688, encodeId=63581484688b8, content=<a href='/topic/show?id=3502102944e7' target=_blank style='color:#2F92EE;'>#鳞癌#</a>, objectTitle=Gastroenterology：颠覆！T1bN0M期食管鳞癌患者采用放化疗治疗的效果不劣于手术！, objectType=article, longId=215857, objectId=3a0b21585eec, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3a0b21585eec, replyNumber=0, likeNumber=79, createdTime=2021-08-18, rootId=0, userName=1696533704_45270456, userId=745a7977375, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3a0b21585eec, moduleTitle=Gastroenterology：颠覆！T1bN0M期食管鳞癌患者采用放化疗治疗的效果不劣于手术！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3a0b21585eec)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1484687, encodeId=efce148468e9a, content=<a href='/topic/show?id=3502102944e7' target=_blank style='color:#2F92EE;'>#鳞癌#</a>, objectTitle=Ⅳ期肺鳞癌病人治疗方案, objectType=article, longId=215303, objectId=3d5e2153031b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3d5e2153031b, replyNumber=0, likeNumber=73, createdTime=2021-08-06, rootId=0, userName=1696533704_45270456, userId=745a7977375, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3d5e2153031b, moduleTitle=Ⅳ期肺鳞癌病人治疗方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3d5e2153031b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1484686, encodeId=27ff1484686f6, content=<a href='/topic/show?id=3502102944e7' target=_blank style='color:#2F92EE;'>#鳞癌#</a>, objectTitle=Br J Cancer：阿司匹林增强顺铂治疗食管鳞癌的疗效, objectType=article, longId=215172, objectId=d9d42151e26a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d9d42151e26a, replyNumber=0, likeNumber=80, createdTime=2021-08-03, rootId=0, userName=1696533704_45270456, userId=745a7977375, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d9d42151e26a, moduleTitle=Br J Cancer：阿司匹林增强顺铂治疗食管鳞癌的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d9d42151e26a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1484685, encodeId=728414846857c, content=<a href='/topic/show?id=3502102944e7' target=_blank style='color:#2F92EE;'>#鳞癌#</a>, objectTitle=Eur J Cancer：紫杉醇在氟嘧啶和铂类难治性食管鳞癌中的效果明显优于多西他赛！, objectType=article, longId=215144, objectId=fb9b21514490, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fb9b21514490, replyNumber=0, likeNumber=82, createdTime=2021-08-03, rootId=0, userName=1696533704_45270456, userId=745a7977375, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fb9b21514490, moduleTitle=Eur J Cancer：紫杉醇在氟嘧啶和铂类难治性食管鳞癌中的效果明显优于多西他赛！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fb9b21514490)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1484684, encodeId=1c191484684f8, content=<a href='/topic/show?id=3502102944e7' target=_blank style='color:#2F92EE;'>#鳞癌#</a>, objectTitle=JAMA Surg：新辅助放化疗联合手术可显著改善中国局部晚期食管鳞癌患者的长期预后, objectType=article, longId=213435, objectId=f68521343500, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f68521343500, replyNumber=0, likeNumber=79, createdTime=2021-06-30, rootId=0, userName=1696533704_45270456, userId=745a7977375, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f68521343500, moduleTitle=JAMA Surg：新辅助放化疗联合手术可显著改善中国局部晚期食管鳞癌患者的长期预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f68521343500)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1484683, encodeId=3fd2148468334, content=<a href='/topic/show?id=3502102944e7' target=_blank style='color:#2F92EE;'>#鳞癌#</a>, objectTitle=Eur J Nucl Med Mol Imaging：采用PERCIST预测食管鳞癌患者对新辅助化疗的肿瘤反应和预后, objectType=article, longId=210896, objectId=ccf4210896f1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ccf4210896f1, replyNumber=0, likeNumber=89, createdTime=2021-05-08, rootId=0, userName=1696533704_45270456, userId=745a7977375, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ccf4210896f1, moduleTitle=Eur J Nucl Med Mol Imaging：采用PERCIST预测食管鳞癌患者对新辅助化疗的肿瘤反应和预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ccf4210896f1)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

鳞癌

2020-05-29

1696533704_45270456 (审核中...)

前往app查看评论内容

#鳞癌#

Front Oncol：复发或转移性头颈部鳞癌(R/M HNSCC)患者使用免疫检查点抑制剂治疗(ICB)的疗效

2022-02-04

1696533704_45270456 (审核中...)

前往app查看评论内容

#鳞癌#

Lancet Gastroenterol Hepatol：郑大一附院王峰教授CAP 02研究显示卡瑞利珠单抗联合阿帕替尼二线治疗晚期食管鳞癌疗效显著

2022-01-16

1696533704_45270456 (审核中...)

前往app查看评论内容

#鳞癌#

Cancer Med：国内多中心随机双盲II期研究表明安罗替尼（Anlotinib）后线治疗较安慰剂改善晚期或转移性食管鳞癌患者的预后

2021-12-30

1696533704_45270456 (审核中...)

前往app查看评论内容

#鳞癌#

J Cancer Res Clin Oncol：广医一院团队真实世界数据发现Sintilimab（信迪利单抗）联合紫杉醇+铂类或可进一步改善晚期肺鳞癌的生存

2021-12-30

1696533704_45270456 (审核中...)

前往app查看评论内容

#鳞癌#

血清HO－1、CA72－4、SCC－Ag联合检测在食管鳞癌诊断中的价值

2021-11-28

1696533704_45270456 (审核中...)

前往app查看评论内容

#鳞癌#

食管鳞癌放疗患者贫血现状及其对预后的影响研究

2021-11-27

1696533704_45270456 (审核中...)

前往app查看评论内容

#鳞癌#

肺癌病例 | 聚焦肺鳞癌，信迪利单抗二线单药治疗经验分享

2021-11-27

1696533704_45270456 (审核中...)

前往app查看评论内容

#鳞癌#

宫颈腺鳞癌 45 例临床分析

2021-11-26

1696533704_45270456 (审核中...)

前往app查看评论内容

#鳞癌#

替吉奥联合同步放疗晚期肺鳞癌及影响因素分析

2021-11-22

1696533704_45270456 (审核中...)

前往app查看评论内容

#鳞癌#

Eur J Cancer：免疫检查点抑制剂在老年头颈部鳞癌患者中的有效性和安全性

2021-09-25

1696533704_45270456 (审核中...)

前往app查看评论内容

#鳞癌#

信迪利单抗联合化疗一线治疗食管鳞癌的Ⅲ期临床研究结果公布（ORIENT-15研究）

2021-09-23

1696533704_45270456 (审核中...)

前往app查看评论内容

#鳞癌#

ESMO Open：Tomuzotuximab vs 西妥昔单抗用作复发/转移性头颈部鳞癌的一线治疗方案的疗效和安全性

2021-09-15

1696533704_45270456 (审核中...)

前往app查看评论内容

#鳞癌#

J Clin Oncol：Veliparib联合卡铂+紫杉醇化疗作为晚期肺鳞癌的一线治疗的效果

2021-08-29

1696533704_45270456 (审核中...)

前往app查看评论内容

#鳞癌#

Eur J Cancer：铂类+5-氟尿嘧啶+西妥昔单抗可作为中国复发/转移性头颈鳞癌患者的新一线治疗方案！

2021-08-25

1696533704_45270456 (审核中...)

前往app查看评论内容

#鳞癌#

Gastroenterology：颠覆！T1bN0M期食管鳞癌患者采用放化疗治疗的效果不劣于手术！

2021-08-18

1696533704_45270456 (审核中...)

前往app查看评论内容

#鳞癌#

Ⅳ期肺鳞癌病人治疗方案

2021-08-06

1696533704_45270456 (审核中...)

前往app查看评论内容

#鳞癌#

Br J Cancer：阿司匹林增强顺铂治疗食管鳞癌的疗效

2021-08-03

1696533704_45270456 (审核中...)

前往app查看评论内容

#鳞癌#

Eur J Cancer：紫杉醇在氟嘧啶和铂类难治性食管鳞癌中的效果明显优于多西他赛！

2021-08-03

1696533704_45270456 (审核中...)

前往app查看评论内容

#鳞癌#

JAMA Surg：新辅助放化疗联合手术可显著改善中国局部晚期食管鳞癌患者的长期预后

2021-06-30

1696533704_45270456 (审核中...)

前往app查看评论内容

#鳞癌#

Eur J Nucl Med Mol Imaging：采用PERCIST预测食管鳞癌患者对新辅助化疗的肿瘤反应和预后

2021-05-08

科室
- - 订阅+
  - 更多科室
工具
服务